The anthracycline antibiotics:: antitumor drugs that alter chromatin structure

被引:121
作者
Rabbani, A
Finn, RM
Ausió, J
机构
[1] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada
[2] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran
关键词
D O I
10.1002/bies.20160
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Anthracycline antibiotics are an important group of antitumor drugs widely used in cancer chemotherapy. However, despite the increasing interest in these chemotherapeutic agents, their mechanism of action is not yet completely understood. Here, we review what is currently known about the molecular mechanisms involved with special emphasis on the interaction of these drugs with chromatin and its constitutive components: DNA and histones. The evidence suggests that one very important component of the activity of these drugs is the result of these manifold interactions that lead to a chromatin unfolding and aggregation. This chromatin structural disruption is likely to interfere with the metabolic processes of DNA (replication and transcription) and it may play an important role in the apoptosis undergone by the cells upon treatment with these drugs. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 74 条
  • [1] [Anonymous], [No title captured]
  • [2] Arcamone F., 1981, DOXORUBICIN ANTICANC
  • [3] Analytical ultracentrifugation and the characterization of chromatin structure
    Ausió, J
    [J]. BIOPHYSICAL CHEMISTRY, 2000, 86 (2-3) : 141 - 153
  • [4] EQUILIBRIUM BINDING OF DAUNOMYCIN AND ADRIAMYCIN TO CALF THYMUS DNA - TEMPERATURE AND IONIC-STRENGTH DEPENDENCE OF THERMODYNAMIC PARAMETERS
    BARCELO, F
    MARTORELL, J
    GAVILANES, F
    GONZALEZROS, JM
    [J]. BIOCHEMICAL PHARMACOLOGY, 1988, 37 (11) : 2133 - 2138
  • [5] Behal V, 2000, ADV APPL MICROBIOL, V47, P113
  • [6] INTERCALATION OF ANTHRACYCLINES INTO LIVING CELL-DNA ANALYZED BY FLOW-CYTOMETRY
    BELLOC, F
    LACOMBE, F
    DUMAIN, P
    LOPEZ, F
    BERNARD, P
    BOISSEAU, MR
    REIFERS, J
    [J]. CYTOMETRY, 1992, 13 (08): : 880 - 885
  • [7] Binaschi M., 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P113, DOI 10.2174/1568011013354723
  • [8] Borchmann P, 2003, HAEMATOLOGICA, V88, P888
  • [9] BRITT M, 1986, MOL PHARMACOL, V29, P74
  • [10] Priming with granulocyte colony-stimulating factor - Relation to high-dose cytarabine in acute myeloid leukemia
    Buchner, T
    Berdel, WE
    Hiddemann, W
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) : 2215 - 2216